drugset / Trial / NCT02057549

Haloperidol vs Conventional Therapy for Gastroparesis

NCT02057549

RandomizedParallel-groupDouble-blindTreatment

Summary

Randomized controlled trial comparing haloperidol combined with conventional therapy and conventional therapy alone in patients with symptomatic gastroparesis.

Timeline

Start
2012-11
Primary completion
2016-11
Completion
2016-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Haloperidol Other / unclassified 5 mg Intravenous

Indications